Utility and correlation of known anticoagulation parameters in the management of pediatric ventricular assist devices

doi:10.4330/wjc.v9.i9.749

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6394)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

382

WORD

256

HTML

2841

Figures (1-4)

170

Tables (1-3)

146

Sum=3795

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

840

Download

1759

Sum=2599

Sep 26, 2017 (publication date) through May 11, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Cardiol. Sep 26, 2017; 9(9): 749-756
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.749

Full Size Figure Download Figure

Figure 3 Scatterplots demonstrating correlation between unfractionated heparin dose and (A) activated thromboplastin time (B) Anti-Xa levels and (C) thromboelastogram-R value. The estimated linear regression line (line of best fit) is shown along with 95%CI for individual value predictions. aPTT: Activated thromboplastin time; TEG: Thromboelastogram.

Citation: Bhatia AK, Yabrodi M, Carroll M, Bunting S, Kanter K, Maher KO, Deshpande SR. Utility and correlation of known anticoagulation parameters in the management of pediatric ventricular assist devices. World J Cardiol 2017; 9(9): 749-756
URL: https://www.wjgnet.com/1949-8462/full/v9/i9/749.htm
DOI: https://dx.doi.org/10.4330/wjc.v9.i9.749